I now have excellent textbook content for all 4 questions. Let me now write all 4 complete university-level answers.Here are all 4 complete university-level 10-mark answers:
✅ Q2 — TCA Cycle (Krebs Cycle / Citric Acid Cycle)
"Explain the reaction sequence, significance & energetics of TCA Cycle"
(Unit II — Carbohydrate Metabolism | 10 Marks)
📌 DEFINITION
The Tricarboxylic Acid (TCA) Cycle / Krebs Cycle / Citric Acid Cycle is a cyclic series of 8 reactions occurring in the mitochondrial matrix in which Acetyl-CoA (2C) combines with Oxaloacetate (4C) to form Citrate (6C), which is then progressively oxidized, releasing CO₂, NADH, FADH₂, and GTP, and regenerating oxaloacetate to continue the cycle.
🔑 Discovered by Sir Hans Krebs in 1937 — Nobel Prize 1953
📌 LOCATION & ENTRY POINT
| Feature | Detail |
|---|
| Site | Mitochondrial matrix |
| Substrate entering | Acetyl-CoA (from pyruvate, fatty acids, amino acids) |
| Link reaction | Pyruvate → Acetyl-CoA (by Pyruvate Dehydrogenase Complex) |
Link Reaction (Pyruvate Dehydrogenase Complex):
Pyruvate + CoA + NAD⁺ → Acetyl-CoA + CO₂ + NADH
Coenzymes needed: TPP, Lipoic acid, FAD, CoA, NAD⁺
📌 THE 8 REACTIONS OF TCA CYCLE
ACETYL-CoA (2C)
+
OXALOACETATE (4C)
↓ ① Citrate Synthase
CITRATE (6C) ← IRREVERSIBLE
↓ ② Aconitase
cis-ACONITATE (6C)
↓ Aconitase
ISOCITRATE (6C)
↓ ③ Isocitrate Dehydrogenase → NADH + CO₂ ← IRREVERSIBLE ⭐
α-KETOGLUTARATE (5C)
↓ ④ α-Ketoglutarate Dehydrogenase → NADH + CO₂ ← IRREVERSIBLE ⭐
SUCCINYL-CoA (4C)
↓ ⑤ Succinyl-CoA Synthetase → GTP (= ATP)
SUCCINATE (4C)
↓ ⑥ Succinate Dehydrogenase → FADH₂
FUMARATE (4C)
↓ ⑦ Fumarase (+ H₂O)
MALATE (4C)
↓ ⑧ Malate Dehydrogenase → NADH
OXALOACETATE (4C) ← Cycle Regenerated ♻️
📌 STEP-BY-STEP TABLE
| Step | Reaction | Enzyme | Product | Reversible? |
|---|
| ① | Acetyl-CoA + OAA → Citrate | Citrate Synthase | Citrate (6C) | ❌ |
| ② | Citrate → Isocitrate | Aconitase | Isocitrate | ✅ |
| ③ | Isocitrate → α-Ketoglutarate | Isocitrate Dehydrogenase ⭐ | NADH + CO₂ | ❌ |
| ④ | α-KG → Succinyl-CoA | α-KG Dehydrogenase ⭐ | NADH + CO₂ | ❌ |
| ⑤ | Succinyl-CoA → Succinate | Succinyl-CoA Synthetase | GTP | ✅ |
| ⑥ | Succinate → Fumarate | Succinate Dehydrogenase | FADH₂ | ✅ |
| ⑦ | Fumarate → Malate | Fumarase | Malate | ✅ |
| ⑧ | Malate → OAA | Malate Dehydrogenase | NADH | ✅ |
⭐ 3 Irreversible steps (Regulated enzymes): Citrate Synthase, Isocitrate DH, α-KG DH
📌 ENERGETICS — ATP BALANCE (Per Acetyl-CoA)
| Coenzyme Produced | Amount | ATP yield (via ETC) |
|---|
| NADH | 3 | 3 × 2.5 = 7.5 ATP |
| FADH₂ | 1 | 1 × 1.5 = 1.5 ATP |
| GTP | 1 | = 1 ATP |
| TOTAL | | ≈ 10 ATP per Acetyl-CoA |
For 1 Glucose → 2 Acetyl-CoA → 20 ATP from TCA (+ 10 from glycolysis + ETC = total ~30-32 ATP)
📌 REGULATION OF TCA CYCLE
LOW Energy (↑ADP/NAD⁺) → ACTIVATE cycle ↑
HIGH Energy (↑ATP/NADH) → INHIBIT cycle ↓
Citrate Synthase → Inhibited by: ATP, NADH, Succinyl-CoA, Citrate
Isocitrate DH ⭐ → Activated by: ADP, Ca²⁺ | Inhibited by: ATP, NADH
α-KG DH ⭐ → Activated by: Ca²⁺ | Inhibited by: Succinyl-CoA, NADH
📌 SIGNIFICANCE (Amphibolic Nature) ✨
TCA CYCLE
│
┌───────────────┼───────────────┐
▼ ▼ ▼
ENERGY (ATP) BIOSYNTHESIS ANAPLEROSIS
(NADH/FADH₂) Precursors (Replenishing
intermediates)
↓ ↓
Oxidative α-KG → Glu Pyruvate → OAA
Phosphory- OAA → Asp (Pyruvate Carboxylase)
lation Succinyl-CoA
→ Heme synthesis
Citrate → Fatty Acids
- Energy production — Main source of NADH/FADH₂ for ETC → ATP
- Amphibolic — Both catabolic AND anabolic (feeds biosynthesis)
- Amino acid synthesis — α-KG → Glutamate; OAA → Aspartate
- Heme synthesis — Succinyl-CoA is precursor of porphyrin ring
- Fatty acid synthesis — Citrate carries Acetyl-CoA out of mitochondria
- Gluconeogenesis — OAA → PEP → Glucose
📌 CLINICAL SIGNIFICANCE
| Condition | Connection |
|---|
| Thiamine (B₁) deficiency | Inhibits α-KG DH (needs TPP) → Wernicke's encephalopathy, Beriberi |
| Arsenic poisoning | Inhibits α-KG DH → blocks TCA |
| Fluoroacetate poisoning | Inhibits Aconitase → Citrate accumulates (lethal synthesis) |
| Malonate | Inhibits Succinate DH (competitive inhibitor) |
✅ Q3 — Gluconeogenesis
"Define Gluconeogenesis & explain the reactions involved with its significance"
(Unit II — Carbohydrate Metabolism | 10 Marks)
📌 DEFINITION
Gluconeogenesis (Latin: gluco = glucose, neo = new, genesis = production) is the metabolic pathway by which glucose is synthesized from non-carbohydrate precursors in the liver (primarily) and kidney cortex (during starvation).
🔑 "Making new glucose when dietary glucose is unavailable"
📌 KEY FEATURES
| Feature | Detail |
|---|
| Site | Liver (mainly), Kidney cortex (starvation) |
| Occurs during | Fasting, starvation, prolonged exercise |
| Main precursors | Lactate, Amino acids (Alanine), Glycerol |
| Stimulated by | Glucagon, Cortisol, Epinephrine |
| Inhibited by | Insulin |
| Energy required | 6 ATP (energy-expensive process) |
📌 PRECURSORS FLOWCHART
LACTATE ─────────────────────────────────┐
(from RBCs, muscle) │
▼
AMINO ACIDS (Alanine, Glutamine) ──► PYRUVATE / OAA ──► GLUCOSE
(from muscle protein) ▲
│
GLYCEROL ─────────────────────────────────┘
(from fat breakdown, TG lipolysis)
→ Glycerol-3-P → DHAP → enters pathway
📌 THE 3 KEY BYPASS REACTIONS
(Because glycolysis has 3 irreversible steps that must be bypassed)
| Glycolysis (irreversible) | Gluconeogenesis Bypass Enzyme |
|---|
| Pyruvate Kinase (PEP → Pyruvate) | Pyruvate Carboxylase (Pyruvate → OAA) + PEPCK (OAA → PEP) |
| PFK-1 (F6P → F1,6-bisP) | Fructose-1,6-bisphosphatase (F1,6-bisP → F6P) |
| Hexokinase (Glucose → G6P) | Glucose-6-Phosphatase (G6P → Glucose) |
📌 REACTION PATHWAY — FLOWCHART
PYRUVATE (cytoplasm)
↓ ① Pyruvate Carboxylase + CO₂ + ATP [Mitochondria]
OXALOACETATE (OAA)
↓ ② PEPCK + GTP → CO₂
PHOSPHOENOLPYRUVATE (PEP)
↓ ③ Same as glycolysis (reverse) × 5 steps
FRUCTOSE-1,6-BISPHOSPHATE
↓ ④ Fructose-1,6-bisphosphatase (− Pᵢ, water) ← BYPASS 2
FRUCTOSE-6-PHOSPHATE
↓ ⑤ Phosphoglucose Isomerase (reverse)
GLUCOSE-6-PHOSPHATE
↓ ⑥ Glucose-6-Phosphatase (−Pᵢ) ← BYPASS 3 [ER membrane]
GLUCOSE (free, enters blood)
⚠️ Note: Steps ③–⑤ use the same enzymes as glycolysis (run in reverse)
📌 ENERGETICS
Net equation (from 2 Pyruvate → 1 Glucose):
2 Pyruvate + 4 ATP + 2 GTP + 2 NADH → Glucose + 4 ADP + 2 GDP + 6 Pᵢ + 2 NAD⁺
| Energy Cost | Amount |
|---|
| ATP consumed | 4 |
| GTP consumed | 2 |
| NADH consumed | 2 |
| Total energy cost | 6 high-energy bonds per glucose |
Gluconeogenesis costs 6 ATP vs glycolysis which yields only 2 ATP — intentionally costly to prevent futile cycling
📌 CORI CYCLE (Special Feature) ✨
MUSCLE (anaerobic) LIVER
Glucose → Lactate →→→→ Lactate → Glucose
(glycolysis) (gluconeogenesis)
↑_____________________________↑
BLOOD
This cycle: Muscle generates lactate → Liver converts it back to glucose → sent back to muscle. Allows RBCs and exercising muscle to function without oxygen.
📌 GLUCOSE-ALANINE CYCLE ✨
MUSCLE LIVER
Pyruvate + NH₃ → Alanine → Alanine → Pyruvate → Glucose
(protein breakdown) (via gluconeogenesis)
Carries nitrogen (as alanine) from muscle to liver for urea synthesis, while recycling carbon skeleton for glucose.
📌 REGULATION
| Enzyme | Activated by | Inhibited by |
|---|
| Pyruvate Carboxylase | Acetyl-CoA | ADP |
| PEPCK | Glucagon/Cortisol (gene induction) | Insulin |
| F-1,6-BPase | Citrate | AMP, Fructose-2,6-bisP |
| G-6-Phosphatase | — | High glucose |
📌 SIGNIFICANCE
- Maintains blood glucose during fasting/starvation
- Brain survival — brain needs continuous glucose (can't use fatty acids well)
- RBC function — RBCs have no mitochondria, depend on glucose
- Recycles lactate — via Cori Cycle
- Amino acid catabolism — provides route for carbon skeletons of amino acids to become glucose
📌 CLINICAL RELEVANCE
| Condition | Mechanism |
|---|
| Fasting hypoglycemia | Failure of gluconeogenesis (liver disease, enzyme deficiency) |
| Diabetes Mellitus (Type 2) | Unregulated gluconeogenesis → persistent hyperglycemia |
| Metformin action | Inhibits hepatic gluconeogenesis (AMPK activation) → lowers blood glucose |
| Von Gierke disease | Glucose-6-Phosphatase deficiency → glucose cannot be released |
✅ Q4 — Biosynthesis of Cholesterol
"Describe the biosynthesis of cholesterol & add a note on role of cholesterol in the body"
(Unit III — Lipid Metabolism | 10 Marks)
📌 DEFINITION
Cholesterol is a 27-carbon sterol synthesized from Acetyl-CoA through the mevalonate pathway. It is an essential component of cell membranes and the precursor of steroid hormones, bile acids, and Vitamin D.
📌 KEY FEATURES
| Feature | Detail |
|---|
| Site | Cytoplasm + ER (smooth endoplasmic reticulum) of liver (mainly) |
| Substrate | Acetyl-CoA |
| Rate-limiting enzyme | HMG-CoA Reductase ⭐ |
| Inhibited by | Statins (drugs), Cholesterol (feedback) |
📌 BIOSYNTHESIS — FLOWCHART (4 Stages)
STAGE 1: SYNTHESIS OF MEVALONATE
══════════════════════════════════
3 × Acetyl-CoA
↓ Thiolase
Acetoacetyl-CoA (4C)
↓ HMG-CoA Synthase + Acetyl-CoA
HMG-CoA (3-Hydroxy-3-Methylglutaryl CoA) (6C)
↓ HMG-CoA Reductase + 2 NADPH ← RATE LIMITING ⭐
MEVALONATE (6C)
STAGE 2: SYNTHESIS OF ISOPRENE UNITS (IPP)
═══════════════════════════════════════════
Mevalonate + 3 ATP
↓ Kinases + Decarboxylase
ISOPENTENYL PYROPHOSPHATE (IPP) (5C) ← Active isoprene unit
↓ Isomerase
DIMETHYLALLYL PYROPHOSPHATE (DPP) (5C)
STAGE 3: SYNTHESIS OF SQUALENE
═══════════════════════════════
IPP (5C) + DPP (5C) → Geranyl-PP (10C) + NADPH
+ IPP (5C) → Farnesyl-PP (15C)
+ Farnesyl-PP (15C) + NADPH
↓ Squalene Synthase
SQUALENE (30C)
STAGE 4: CYCLIZATION → CHOLESTEROL
════════════════════════════════════
Squalene (30C)
↓ Squalene Epoxidase + O₂ + NADPH
Squalene-2,3-epoxide
↓ Cyclase
LANOSTEROL (30C)
↓ 20 reactions (ER enzymes)
- Remove 3 methyl groups
- Reduce double bonds
- Shift double bond
CHOLESTEROL (27C) ✅
📌 STAGE SUMMARY TABLE
| Stage | Input | Output | Key Enzyme |
|---|
| 1 | 3 Acetyl-CoA | Mevalonate | HMG-CoA Reductase ⭐ |
| 2 | Mevalonate | IPP (5C) | Kinases, Decarboxylase |
| 3 | IPP units | Squalene (30C) | Squalene Synthase |
| 4 | Squalene | Cholesterol (27C) | Squalene Epoxidase, Cyclase |
Total: 18 ATP + 13 NADPH consumed per cholesterol molecule
📌 REGULATION OF CHOLESTEROL SYNTHESIS
HIGH intracellular cholesterol
↓
① Inhibits HMG-CoA Reductase (feedback)
② Decreases LDL receptor expression
③ Increases ACAT (esterifies excess cholesterol for storage)
LOW intracellular cholesterol
↓
① SREBP activated → increases HMG-CoA Reductase gene expression
② Increases LDL receptors → uptakes more LDL cholesterol
| Regulator | Effect on HMG-CoA Reductase |
|---|
| Insulin, Thyroid hormone | ↑ Activate |
| Glucagon, Cortisol | ↓ Inhibit |
| Cholesterol (feedback) | ↓ Inhibit |
| Statins (drugs) | ❌ Competitively inhibit |
📌 ROLE OF CHOLESTEROL IN THE BODY ✨
CHOLESTEROL
│
┌────────────────┼──────────────────┐
▼ ▼ ▼
CELL MEMBRANES PRECURSOR OF: VITAMIN D
(fluidity & Steroid hormones (7-dehydrocholesterol
structure) Bile acids in skin → UV → Vit D₃)
│ │
Every cell HORMONES:
membrane - Cortisol
contains - Aldosterone
cholesterol - Estrogen
- Testosterone
- Progesterone
| Role | Description |
|---|
| Cell membrane | Regulates membrane fluidity and permeability |
| Bile acids | Cholesterol → Bile acids (liver) → fat digestion & absorption |
| Steroid hormones | Precursor of all adrenal & sex hormones |
| Vitamin D | 7-dehydrocholesterol → Vitamin D₃ (skin, UV light) |
| Myelin sheath | Component of myelin — nerve conduction |
| Lipoproteins | Transported as LDL, HDL, VLDL in blood |
📌 CLINICAL SIGNIFICANCE
| Condition | Mechanism |
|---|
| Atherosclerosis | LDL-cholesterol deposition in arterial walls → plaques |
| Familial Hypercholesterolemia | LDL receptor deficiency → very high LDL → early heart disease |
| Gallstones (Cholelithiasis) | Excess cholesterol precipitates in bile |
| Statins (Atorvastatin, Simvastatin) | Block HMG-CoA Reductase → lower blood cholesterol |
| Smith-Lemli-Opitz Syndrome | 7-dehydrocholesterol reductase deficiency → impaired cholesterol synthesis → malformations |
✅ Q5 — Ketone Bodies
"What are Ketone Bodies? Explain formation & importance"
(Unit III — Lipid Metabolism | 10 Marks)
📌 DEFINITION
Ketone bodies are water-soluble, small acidic compounds produced in the liver mitochondria from Acetyl-CoA (derived from fatty acid β-oxidation) during conditions of increased fatty acid oxidation (fasting, starvation, uncontrolled diabetes). They serve as an important alternative fuel for brain, heart, and muscle.
📌 THE THREE KETONE BODIES
| Ketone Body | Notes |
|---|
| Acetoacetate | Primary ketone body; can be used as fuel |
| 3-Hydroxybutyrate (β-hydroxybutyrate) | Most abundant in blood (~75%); most important fuel form |
| Acetone | Volatile; formed by spontaneous decarboxylation of acetoacetate; exhaled via lungs (fruity breath in DKA) |
📌 CONDITIONS PROMOTING KETONE BODY SYNTHESIS
Starvation / Fasting
Uncontrolled Diabetes Mellitus (Type 1)
Low-carbohydrate diet (ketogenic diet)
Prolonged exercise
Alcoholism
↓
↑ Fatty acid mobilization from adipose tissue
↓
↑ Acetyl-CoA in liver (from β-oxidation)
↓ (OAA depleted — used for gluconeogenesis)
Acetyl-CoA cannot enter TCA cycle
↓
→ KETONE BODY SYNTHESIS ↑
📌 KETOGENESIS (Formation) — FLOWCHART
FATTY ACIDS → β-Oxidation → ACETYL-CoA (×many)
│
┌────────────────────────┘
↓
2 Acetyl-CoA
↓ ① Thiolase (reversal of β-oxidation)
ACETOACETYL-CoA (4C)
↓ ② HMG-CoA Synthase (mitochondrial) + Acetyl-CoA
HMG-CoA (6C) ← RATE LIMITING STEP ⭐
↓ ③ HMG-CoA Lyase
ACETOACETATE + Acetyl-CoA
│
├─ ④ Spontaneous decarboxylation → ACETONE (exhaled)
│
└─ ⑤ 3-Hydroxybutyrate Dehydrogenase + NADH
↓
3-HYDROXYBUTYRATE (main circulating form)
📌 STEP-BY-STEP TABLE
| Step | Reaction | Enzyme | Location |
|---|
| ① | 2 Acetyl-CoA → Acetoacetyl-CoA | Thiolase | Mitochondria |
| ② | Acetoacetyl-CoA + Acetyl-CoA → HMG-CoA | HMG-CoA Synthase ⭐ | Mitochondria |
| ③ | HMG-CoA → Acetoacetate + Acetyl-CoA | HMG-CoA Lyase | Mitochondria |
| ④ | Acetoacetate → Acetone + CO₂ | Spontaneous | Blood |
| ⑤ | Acetoacetate + NADH → 3-Hydroxybutyrate | 3-HB Dehydrogenase | Mitochondria |
⚠️ Note: HMG-CoA Synthase in mitochondria = Ketogenesis; HMG-CoA Synthase in cytoplasm = Cholesterol synthesis (different compartments!)
📌 KETOLYSIS (Use of Ketone Bodies by Peripheral Tissues)
3-HYDROXYBUTYRATE (from blood)
↓ 3-HB Dehydrogenase → NAD⁺ → NADH
ACETOACETATE
↓ + Succinyl-CoA (Thiophorase/Succinyl-CoA transferase) → Succinate
ACETOACETYL-CoA
↓ Thiolase
2 × ACETYL-CoA
↓ TCA Cycle
CO₂ + H₂O + ATP ✅
🚫 Liver cannot use its own ketone bodies — lacks Thiophorase enzyme (succinyl-CoA:acetoacetate CoA transferase). Liver makes ketones for others.
📌 ENERGY YIELD FROM KETONE BODIES
| Molecule | ATP Produced |
|---|
| 1 Acetoacetate → 2 Acetyl-CoA → TCA | ~23 ATP |
| 1 3-Hydroxybutyrate → TCA | ~26 ATP |
Ketone bodies are efficient fuels — especially for brain during prolonged fasting (after 3–4 days, brain shifts from glucose to ketone bodies)
📌 IMPORTANCE / SIGNIFICANCE ✨
KETONE BODIES
│
┌─────────────┼──────────────┐
▼ ▼ ▼
ENERGY SOURCE BRAIN FUEL PROTEIN SPARING
(heart, muscle (during (reduces need to
kidney use) starvation) break down muscle
protein in fasting)
- Alternative fuel — Heart, renal cortex prefer ketone bodies over glucose
- Brain adaptation — After 3–4 days fasting, brain uses ketone bodies (normally can't use fat) → spares glucose for RBCs
- Protein sparing — Reduces muscle protein catabolism during starvation
- Signal molecule — β-hydroxybutyrate acts as an HDAC inhibitor (epigenetic regulation)
- Ketogenic diet — Used therapeutically in epilepsy, Type 2 diabetes management
📌 REGULATION
| Factor | Effect |
|---|
| ↑ Fatty acids (fasting) | ↑ Ketogenesis |
| ↑ Glucagon | ↑ Ketogenesis (activates lipolysis) |
| Insulin | ↓ Ketogenesis (inhibits lipolysis) |
| ↑ Acetyl-CoA + ↓ OAA | ↑ Ketogenesis (can't enter TCA) |
📌 CLINICAL SIGNIFICANCE
| Condition | Connection |
|---|
| Diabetic Ketoacidosis (DKA) | No insulin → uncontrolled ketogenesis → ketoacidosis → coma/death |
| Fruity breath | Acetone exhaled in DKA/starvation |
| Ketonuria | Ketone bodies in urine (detected by nitroprusside test) |
| Starvation ketosis | Normal physiological response to prolonged fasting |
| Alcoholic ketoacidosis | Alcohol → NADH↑ → OAA depleted → TCA blocked → ketones ↑ |
| Ketogenic diet | Therapeutic for drug-resistant epilepsy, weight loss, Type 2 DM |
📌 DKA vs Starvation Ketosis
| Feature | DKA | Starvation Ketosis |
|---|
| Cause | Insulin deficiency (Type 1 DM) | Prolonged fasting |
| Severity | Severe (pH <7.3) | Mild (compensated) |
| Blood glucose | Very HIGH | LOW/Normal |
| Insulin level | Very LOW | Slightly low |
| Danger | Life-threatening | Physiological adaptation |
References: Lippincott Illustrated Reviews: Biochemistry, 8th Ed.; Basic Medical Biochemistry: A Clinical Approach, 6th Ed.; Harper's Illustrated Biochemistry, 32nd Ed.
---Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.